1. Home
  2. SON vs TVTX Comparison

SON vs TVTX Comparison

Compare SON & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$49.56

Market Cap

4.9B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$44.38

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
TVTX
Founded
1899
N/A
Country
United States
United States
Employees
N/A
497
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.1B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
SON
TVTX
Price
$49.56
$44.38
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$60.13
$40.62
AVG Volume (30 Days)
1.3M
2.0M
Earning Date
04-21-2026
05-04-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
92.89
EPS
0.68
N/A
Revenue
$7,518,753,000.00
N/A
Revenue This Year
$0.10
$44.76
Revenue Next Year
$1.82
$35.51
P/E Ratio
$71.64
N/A
Revenue Growth
41.72
N/A
52 Week Low
$38.65
$13.88
52 Week High
$58.44
$48.61

Technical Indicators

Market Signals
Indicator
SON
TVTX
Relative Strength Index (RSI) 46.93 61.88
Support Level $46.73 $41.55
Resistance Level $52.71 $48.61
Average True Range (ATR) 1.32 2.22
MACD -0.02 -0.34
Stochastic Oscillator 52.57 43.35

Price Performance

Historical Comparison
SON
TVTX

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: